Utilization Pattern of Tumor Necrosis Factor alpha Inhibitors among Patients with Rheumatologic Arthritis in Korea

被引：0
|
作者：
Lee, Joongyub [1 ]
Choi, Nam-Kyong [1 ]
Yang, Bo Ram [1 ]
Jin, Xue-Mei [2 ]
Park, Byung-Joo [2 ,3 ]
机构：
[1] Seoul Natl Univ Hosp, Seoul 110744, South Korea
[2] Seoul Natl Univ Coll Med, Seoul, South Korea
[3] Korea Inst Drug Safety & Risk Management, Seoul, South Korea
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
876
引用
收藏
页码：471 / 471
页数：1
相关论文
共 50 条
  • [31] Tumor necrosis factor-alpha inhibitors and risk of non-Hodgkin lymphoma in a cohort of adults with rheumatologic conditions
    Calip, Gregory S.
    Patel, Pritesh R.
    Adimadhyam, Sruthi
    Xing, Shan
    Wu, Zhaoju
    Sweiss, Karen
    Schumock, Glen T.
    Lee, Todd A.
    Chiu, Brian C. -H.
    INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (05) : 1062 - 1071
  • [32] Longterm Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis
    Emery, Paul
    Vlahos, Bonnie
    Szczypa, Piotr
    Thakur, Mazhar
    Jones, Heather E.
    Woolcott, John
    Estrella, Paul V. Santos
    Rolland, Catherine
    Gibofsky, Allan
    Citera, Gustavo
    Sockalingam, Sargunan
    Marshall, Lisa
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (04) : 493 - 501
  • [33] Predictors of tumor necrosis factor inhibitors primary failure in rheumatoid arthritis patients
    Khafagi, Amira Mohamed
    Mosa, Doaa Mosad
    Hawaas, Salah
    Hafez, Eman Abdelrazek
    EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2024, 51 (01)
  • [34] Perspectives on Treatment Burden for Methotrexate and Tumor Necrosis Factor Inhibitors Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis: A Qualitative Study
    Ogdie, Alexis
    Shaw, Yomei
    Almonte, Michele
    Maksabedian, Hernande Ervant J.
    Stolshek, Bradley
    Michaud, Kaleb
    ACR OPEN RHEUMATOLOGY, 2023, 5 (04) : 167 - 172
  • [35] Tumor Necrosis Factor Inhibitors and the Risk of Cancer among Older Americans with Rheumatoid Arthritis
    D'Arcy, Monica E.
    Beachler, Daniel C.
    Pfeiffer, Ruth M.
    Curtis, Jeffrey R.
    Mariette, Xavier
    Seror, Raphaele
    Mahale, Parag
    Rivera, Donna R.
    Yanik, Elizabeth L.
    Engels, Eric A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (11) : 2059 - 2067
  • [36] Comparative Effectiveness of Tocilizumab Monotherapy with Tumor Necrosis Factor Inhibitors in Combination with Methotrexate in Patients with Rheumatoid Arthritis and Prior Exposure to Tumor Necrosis Factor Inhibitors
    Harrold, Leslie R.
    Reed, George W.
    Best, Jennie
    Zlotnick, Steve
    Persuitte, Gioia
    Kremer, Joel M.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [37] Tumor necrosis factor alpha promoter polymorphisms in patients with juvenile idiopathic arthritis
    Schmeling, H
    Wagner, U
    Peterson, A
    Horneff, G
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (01) : 103 - 108
  • [38] Medication Effectiveness with the Use of Tumor Necrosis Factor Inhibitors Among Texas Medicaid Patients Diagnosed with Rheumatoid Arthritis
    Oladapo, Abiola
    Barner, Jamie C.
    Lawson, Kenneth A.
    Novak, Suzanne
    Rascati, Karen L.
    Richards, Kristin M.
    Harrison, David J.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2014, 20 (07): : 657 - 667
  • [39] HEALTH CARE UTILIZATION COSTS AND MEDICATION USE PATTERNS OF TUMOR NECROSIS FACTOR (TNF) INHIBITORS AMONG TEXAS MEDICAID PATIENTS DIAGNOSED WITH RHEUMATOID ARTHRITIS
    Oladapo, A.
    Barner, J. C.
    Richards, K.
    Rascati, K. L.
    Lawson, K. A.
    Novak, S.
    Harrison, D. J.
    VALUE IN HEALTH, 2014, 17 (03) : A55 - A55
  • [40] DRUG SURVIVAL OF TUMOR NECROSIS FACTOR-α INHIBITORS IN PATIENTS WITH ANKYLOSING SPONDYLITIS IN KOREA
    Jeong, H.
    Kim, H.
    Oh, J. -M.
    Kim, J.
    Lee, J.
    Koh, E. -M.
    Cha, H. -S.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 804 - 804
12345